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Abstract
Recon 2 is a highly curated reconstruction of the human metabolic network. Whilst the
network is state of the art, it has shortcomings, including the presence of unbalanced
reactions involving generic metabolites. By replacing these generic molecules with each of
their specific instances, we can ensure full elemental balancing, in turn allowing constraint-
based analyses to be performed. The resultant model, called Recon 2.1, is an order of
magnitude larger than the original.
Introduction
A comprehensive, curated, consensus reconstruction of the human metabolic network, known
as “Recon 2”, was released in 2013 [1]. Its development followed a jamboree approach [2, 3],
exploiting both genomic and literature data to expand upon existing models [4–6].
The reconstruction is primarily described and made available in SBML (Systems Biology
Markup Language, http://sbml.org/), an established community XML format for the mark-up
of biochemical models that is understood by a large number of software applications [7]. Cel-
lular compartments, metabolites, genes and enzymes are annotated using ontological terms.
These annotations provide the facility to assign definitive terms to individual components,
allowing software to identify such components unambiguously and thus link model compo-
nents to existing data resources [8]. MIRIAM–compliant annotations have been used to
identify components unambiguously by associating them with one or more terms from pub-
licly available databases [9, 10]. Thus this network is entirely traceable and is presented as a
computational framework.
In contrast to other resources such as KEGG [11], Recon 2 acts not only as a knowledge-
base, but also as a predictive model, amenable to constraint-based approaches such as flux
balance analysis [12]. Whilst it represents the state of the art of public human metabolic
network reconstructions, it does have known shortcomings [13]. It is anticipated that the
reconstruction will undergo a cycle of iterative improvement and release, following the strategy
adopted in baker’s yeast [2, 14–17].
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Carbon balancing
Amongst the reconstruction’s problems are the presence of reactions involving generic metabo-
lites. This can lead to elemental imbalances and violation of mass-balance. Consider Figure 1,
which presents three exemplar reactions from the model. The first reaction sees a generic fatty
acid R-group transfer from a CoA to a DHAP. Such reactions provide a template which is
assumed to be followed by all fatty acid side groups. However, to function as a model, there
need to be connections between these generic molecules and their specific counterparts. Thus
the other reactions see a specific to generic reaction, with myristoyl–CoA converted to R–CoA,
and a generic-to-specific reaction, with R–CoA converted to palmitoyl–CoA.
It is clear that, taken together, the second and third reactions are unbalanced, providing a
mechanism for the model to generate two carbons “for free”. In turn, this will mean that any
analyses examining carbon-limited growth, for example, will give unreliable results. Indeed
Recon 2 can grow in the absence of any carbon source.
One method for overcoming this issue is to assign an (albeit arbitrary) number of carbons
to each R-group. Then, through modification of the stoichiometry of the generic metabolite,
each reaction may be balanced. Assigning R to contain 16 carbons (as proposed in [4]), and
changing the product stoichiometry as denoted in Figure 1, all three equations become carbon
balanced.
This methodology is applied to all reactions in the model. Various other small changes are
also made, such as ensuring that all non-generic molecules are assigned a formula, and the
definition of a minimal medium (see below). The resultant network, which we shall denote
“Recon 2.1”, is fully carbon balanced (see Table 1) and may be used as a model in constraint-
based analyses.
Minimal medium
A minimal set of nutrients is defined on which the cell is allowed to grow: glucose, ammonium,
oxygen, phosphate and sulphate; the essential amino acids histidine, isoleucine, leucine,
lysine, methionine, phenylalanine, threonine, tryptophan, and valine; the essential fatty acids
α-linoleate and linoleate; dietary minerals of calcium, chloride, iron, potassium, and sodium;
vitamins B2 and B5; and protons and water.
Typically, analyses (for example, those presented in [18]) would proceed based on there being
a single limiting nutrient, which leads to a constant growth yield. Here, however, the model
may use glucose or fatty acids as carbohydrate sources, and thus may grow without any
glucose present. Instead of limiting glucose uptake, we limit the total carbon uptake of the
cell. From a practical perspective, this is achieved by first splitting each exchange reaction
into its import and export parts. A carbon meta-reactant in then added to import reactions
with stoichiometry equal to the number of carbons of that metabolite. For example:
glucoseboundary + 6 carbons −→ glucose extracellular
The total carbon uptake limit is then set to six flux units, equivalent to a typical glucose
uptake limit of one flux unit.
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R C21 + C3 R C3 + C21
C14 C21
(
14+21
16+21
)
R C21
R C21 C16 C21
Figure 1: Examples of reactions found in Recon 2 involving generic metaboites. C3:
dihydroxyacetone phosphate, C14: myristate, C16: palmitate, C21: coenzyme A, R: generic
fatty acid.
C14 C21 + C3 C14 C3 + C21
C16 C21 + C3 C16 C3 + C21
Figure 2: Specific versions of the generic reactions in Figure 1.
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Elemental balancing
The method outlined above creates a model that is carbon balanced. However, the same is
not true of other elements. To ensure that the model is elementally balanced, all generic
molecules must be replaced by their specific counterparts. For the example in Figure 1, this
means creating a new reaction for each possible R-group, and removing any specific-to-generic
interconversions (see Figure 2).
A choice has to be made as to which fatty acids to include in this expansion as it may lead to
a combinatorial explosion; given n possible R-groups, there are n3 possible triglycerides. To
strike a balance between complexity and completeness, we include the eight most commonly
found fatty acids in triglycerides [19]: myristate (14:0), palmitate (16:0), palmitoleate (16:1),
stearate (18:0), oleate (18:1), linoleate (18:2), α-linoleate (18:3) and γ-linoleate (18:3).
The methodology was applied to Recon 2.1 and the resultant model, which we shall term
“Recon 2.1x”, was significantly larger and elementally balanced (see Table 1) . Two reactions
were not expanded: cardiolipin synthase, as cardiolipin contains four R-groups (and thus
n
4 possible configurations), and the biomass reaction. Instead, for generic species in these
reactions only, “is a” reactions [15] of the form of the second example in Figure 1 are added.
Such reactions are not included in the statistics for Table 1.
Recon 2 Recon 2.1 Recon 2.1x
reactions 7440 8089 71159
variables 5063 5056 13940
carbon-
balanced 5553 8089 71159
unbalanced 562 0 0
unknown 1325 0 0
element-
balanced 5504 7461 71157
unbalanced 611 0 0
unknown 1325 628 2
Table 1: Statistics of the original model (Recon 2), the carbon balanced version (Recon 2.1)
and the expanded, element balanced version (Recon 2.1x).
Summary
In this paper, we have modified the human metabolic reconstruction through defining a
minimal medium for growth, and ensuring all reactions are at least carbon balanced. This will
allow the use of the reconstruction as a model, for example in constraint-based analyses. We
have also produced an elementally balanced model, through removal of all generic metabolites.
This process increases the model size from around 104 to 105 reactions and serves as a guide
to the size of model that software developers should strive to support.
We also see a three-fold increase in the number of metabolites in the model, primarily through
a finer description of the lipids therein. Nonetheless, the number of unique metabolites still
falls well short of the forty thousand defined in HMDB [20]. We acknowledge that this work
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forms one further step in the iterative network reconstruction process, towards the ultimate
goal of a complete description of human metabolism [21,22].
Supplementary material The models described above are available in SBML format [7]
from the BioModels database [23]. Their accession numbers are:
• Recon 2.1: MODEL1311110000
• Recon 2.1x: MODEL1311110001
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